Literature DB >> 16373840

Mts1/S100A4 stimulates human pulmonary artery smooth muscle cell migration through multiple signaling pathways.

Edda Spiekerkoetter1, Allan Lawrie, Sandra Merklinger, Noona Ambartsumian, Eugene Lukanidin, Ann-Marie Schmidt, Marlene Rabinovitch.   

Abstract

Entities:  

Mesh:

Year:  2005        PMID: 16373840     DOI: 10.1378/chest.128.6_suppl.577S

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  5 in total

Review 1.  A comprehensive review: the evolution of animal models in pulmonary hypertension research; are we there yet?

Authors:  Gerald Maarman; Sandrine Lecour; Ghazwan Butrous; Friedrich Thienemann; Karen Sliwa
Journal:  Pulm Circ       Date:  2013-12       Impact factor: 3.017

Review 2.  S100A4: a common mediator of epithelial-mesenchymal transition, fibrosis and regeneration in diseases?

Authors:  Mikael Schneider; Jakob L Hansen; Søren P Sheikh
Journal:  J Mol Med (Berl)       Date:  2008-03-06       Impact factor: 4.599

3.  Long non-coding RNA LOC285194 inhibits proliferation and migration but promoted apoptosis in vascular smooth muscle cells via targeting miR-211/PUMA and TGF-β1/S100A4 signal.

Authors:  Shaochun Wang; Ping Li; Gang Jiang; Jinping Guan; Dong Chen; Xiaoying Zhang
Journal:  Bioengineered       Date:  2020-12       Impact factor: 3.269

4.  Identifying early pulmonary arterial hypertension biomarkers in systemic sclerosis: machine learning on proteomics from the DETECT cohort.

Authors:  Yasmina Bauer; Simon de Bernard; Peter Hickey; Karri Ballard; Jeremy Cruz; Peter Cornelisse; Harbajan Chadha-Boreham; Oliver Distler; Daniel Rosenberg; Martin Doelberg; Sebastien Roux; Oliver Nayler; Allan Lawrie
Journal:  Eur Respir J       Date:  2021-06-24       Impact factor: 16.671

5.  Macrophage-Secreted S100A4 Supports Breast Cancer Metastasis by Remodeling the Extracellular Matrix in the Premetastatic Niche.

Authors:  Yana Qi; Tingting Zhao; Ranran Li; Mingyong Han
Journal:  Biomed Res Int       Date:  2022-04-20       Impact factor: 3.246

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.